195 related articles for article (PubMed ID: 25256673)
1. The effect of CCL19/CCR7 on the proliferation and migration of cell in prostate cancer.
Peng C; Zhou K; An S; Yang J
Tumour Biol; 2015 Jan; 36(1):329-35. PubMed ID: 25256673
[TBL] [Abstract][Full Text] [Related]
2. CC-chemokine receptor 7 is overexpressed and correlates with growth and metastasis in prostate cancer.
Chen Y; Tian Y; Ji Z; Liu Z; Shang D
Tumour Biol; 2015 Jul; 36(7):5537-41. PubMed ID: 25682287
[TBL] [Abstract][Full Text] [Related]
3. Antitumor efficacy of CC motif chemokine ligand 19 in colorectal cancer.
Lu J; Zhao J; Feng H; Wang P; Zhang Z; Zong Y; Ma J; Zheng M; Lu A
Dig Dis Sci; 2014 Sep; 59(9):2153-62. PubMed ID: 24705643
[TBL] [Abstract][Full Text] [Related]
4. CCL19 suppresses gastric cancer cell proliferation, migration, and invasion through the CCL19/CCR7/AIM2 pathway.
Zhou R; Sun J; He C; Huang C; Yu H
Hum Cell; 2020 Oct; 33(4):1120-1132. PubMed ID: 32564199
[TBL] [Abstract][Full Text] [Related]
5. CIP2A mediates prostate cancer progression via the c-Myc signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 Jun; 36(6):4777-83. PubMed ID: 25636449
[TBL] [Abstract][Full Text] [Related]
6. CIP2A mediates prostate cancer progression via the c-MYC signaling pathway.
Guo Z; Liu D; Su Z
Tumour Biol; 2015 May; 36(5):3583-9. PubMed ID: 25560487
[TBL] [Abstract][Full Text] [Related]
7. CCR7 mediates human breast cancer cell invasion, migration by inducing epithelial-mesenchymal transition and suppressing apoptosis through AKT pathway.
Xu B; Zhou M; Qiu W; Ye J; Feng Q
Cancer Med; 2017 May; 6(5):1062-1071. PubMed ID: 28378417
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of chemokine (C-C motif) receptor 7 sialylation suppresses CCL19-stimulated proliferation, invasion and anti-anoikis.
Su ML; Chang TM; Chiang CH; Chang HC; Hou MF; Li WS; Hung WC
PLoS One; 2014; 9(6):e98823. PubMed ID: 24915301
[TBL] [Abstract][Full Text] [Related]
9. The effect of chemokine CC motif ligand 19 on the proliferation and migration of hepatocellular carcinoma.
Luo KQ; Shi YN; Peng JC
Tumour Biol; 2014 Dec; 35(12):12575-81. PubMed ID: 25225162
[TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase-9 is up-regulated by CCL19/CCR7 interaction via PI3K/Akt pathway and is involved in CCL19-driven BMSCs migration.
Zhang W; Tu G; Lv C; Long J; Cong L; Han Y
Biochem Biophys Res Commun; 2014 Aug; 451(2):222-8. PubMed ID: 25086360
[TBL] [Abstract][Full Text] [Related]
11. Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.
Chi BJ; Du CL; Fu YF; Zhang YN; Wang RW
Int J Clin Exp Pathol; 2015; 8(10):12533-40. PubMed ID: 26722441
[TBL] [Abstract][Full Text] [Related]
12. An assessment of the relationship between the expression of CCR7/CCL19 axis and selected regulatory miRNAs in non-small cell lung cancer.
Baran K; Kiszałkiewicz J; Migdalska-Sęk M; Jabłoński S; Kordiak J; Antczak A; Góralska K; Brzeziańska-Lasota E
Mol Biol Rep; 2019 Oct; 46(5):5389-5396. PubMed ID: 31463641
[TBL] [Abstract][Full Text] [Related]
13. Construction of ceRNA prognostic model based on the CCR7/CCL19 chemokine axis as a biomarker in breast cancer.
Ma R; Guan X; Teng N; Du Y; Ou S; Li X
BMC Med Genomics; 2023 Oct; 16(1):254. PubMed ID: 37864213
[TBL] [Abstract][Full Text] [Related]
14. CCL19-induced chemokine receptor 7 activates the phosphoinositide-3 kinase-mediated invasive pathway through Cdc42 in metastatic squamous cell carcinoma of the head and neck.
Zhao ZJ; Liu FY; Li P; Ding X; Zong ZH; Sun CF
Oncol Rep; 2011 Mar; 25(3):729-37. PubMed ID: 21165582
[TBL] [Abstract][Full Text] [Related]
15. CCL19/CCR7 contributes to the pathogenesis of endometriosis via PI3K/Akt pathway by regulating the proliferation and invasion of ESCs.
Diao R; Wei W; Zhao J; Tian F; Cai X; Duan YG
Am J Reprod Immunol; 2017 Nov; 78(5):. PubMed ID: 28856757
[TBL] [Abstract][Full Text] [Related]
16. Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.
Cheng S; Guo J; Yang Q; Yang X
Med Oncol; 2015 Mar; 32(3):47. PubMed ID: 25636509
[TBL] [Abstract][Full Text] [Related]
17. Arrestin 3 mediates endocytosis of CCR7 following ligation of CCL19 but not CCL21.
Byers MA; Calloway PA; Shannon L; Cunningham HD; Smith S; Li F; Fassold BC; Vines CM
J Immunol; 2008 Oct; 181(7):4723-32. PubMed ID: 18802075
[TBL] [Abstract][Full Text] [Related]
18. Autocrine and paracrine chemokine receptor 7 activation in head and neck cancer: implications for therapy.
Wang J; Seethala RR; Zhang Q; Gooding W; van Waes C; Hasegawa H; Ferris RL
J Natl Cancer Inst; 2008 Apr; 100(7):502-12. PubMed ID: 18364504
[TBL] [Abstract][Full Text] [Related]
19. Fluorescently Tagged CCL19 and CCL21 to Monitor CCR7 and ACKR4 Functions.
Purvanov V; Matti C; Samson GPB; Kindinger I; Legler DF
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518137
[TBL] [Abstract][Full Text] [Related]
20. The Important Role of the Chemokine Axis CCR7-CCL19 and CCR7-CCL21 in the Pathophysiology of the Immuno-inflammatory Response in Dry Eye Disease.
Wang T; Li W; Cheng H; Zhong L; Deng J; Ling S
Ocul Immunol Inflamm; 2021 Feb; 29(2):266-277. PubMed ID: 31702421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
